Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models.

OBJECTIVE To identify epigenetic factors that are implicated in the pathogenesis of rheumatoid arthritis (RA), and to explore the therapeutic potential of the targeted inhibition of these factors. METHODS Polymerase chain reaction (PCR) arrays were used to investigate the expression profile of genes that encode key epigenetic regulator enzymes. Mononuclear cells from RA patients and mice were monitored for gene expression changes, in association with arthritis development in murine models of RA. Selected genes were further characterized by quantitative reverse transcription-PCR, Western blot, and flow cytometry methods. The targeted inhibition of the up-regulated enzymes was studied in arthritic mice. RESULTS A set of genes with arthritis-specific expression was identified by the PCR arrays. Aurora kinases A and B, both of which were highly expressed in arthritic mice and treatment-naive RA patients, were selected for detailed analysis. Elevated aurora kinase expression was accompanied by increased phosphorylation of histone H3, which promotes proliferation of T lymphocytes. Treatment with VX-680, a pan-aurora kinase inhibitor, promoted B cell apoptosis, provided significant protection against disease onset, and attenuated inflammatory reactions in arthritic mice. CONCLUSION Arthritis development is accompanied by changes in expression of a number of epigenome-modifying enzymes. Drug-induced down-regulation of the aurora kinases, among other targets, seems to be sufficient to treat experimental arthritis. Development of new therapeutics that target aurora kinases can potentially improve RA management.

[1]  A. Yoshimura,et al.  IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. , 2011, International immunology.

[2]  D. Skalnik,et al.  CXXC Finger Protein 1 Contains Redundant Functional Domains That Support Embryonic Stem Cell Cytosine Methylation, Histone Methylation, and Differentiation , 2009, Molecular and Cellular Biology.

[3]  S. Gabriel,et al.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years , 2003, Annals of the rheumatic diseases.

[4]  T. Glant,et al.  Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. , 1987, Arthritis and rheumatism.

[5]  Hong Liu,et al.  Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase , 2010, Proceedings of the National Academy of Sciences.

[6]  J. Berlin,et al.  Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics? , 2010, Molecular Cancer Therapeutics.

[7]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[8]  C. Allis,et al.  Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases , 2002, Molecular and Cellular Biology.

[9]  P. Atadja,et al.  The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance , 2009, Nature Immunology.

[10]  B. Nakken,et al.  B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives. , 2011, Autoimmunity reviews.

[11]  E. Ballestar.  Epigenetic alterations in autoimmune rheumatic diseases , 2011, Nature Reviews Rheumatology.

[12]  K. Nakai,et al.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.

[13]  T. Glant,et al.  Impaired activation-induced cell death promotes spontaneous arthritis in antigen (cartilage proteoglycan)-specific T cell receptor-transgenic mice. , 2010, Arthritis and rheumatism.

[14]  H. Moch,et al.  Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. , 2007, Arthritis and rheumatism.

[15]  P. Tak,et al.  B Lymphocyte Autoimmunity in Rheumatoid Synovitis Is Independent of Ectopic Lymphoid Neogenesis1 , 2008, The Journal of Immunology.

[16]  T. Glant,et al.  Anti-CD44 treatment abrogates tissue aedema and leukocyte infiltration in murine arthrtis , 1995, Nature Medicine.

[17]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[18]  M. Leandro,et al.  B-cell therapies in established rheumatoid arthritis. , 2011, Best practice & research. Clinical rheumatology.

[19]  T. Glant,et al.  Disease‐Associated Qualitative and Quantitative Trait Loci in Proteoglycan‐Induced Arthritis and Collagen‐Induced Arthritis , 2004, The American journal of the medical sciences.

[20]  K. Kinzler,et al.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Yong-Yeon Cho,et al.  Role of NEK6 in Tumor Promoter-induced Transformation in JB6 C141 Mouse Skin Epidermal Cells* , 2010, The Journal of Biological Chemistry.

[22]  B. Kotzin.  The role of B cells in the pathogenesis of rheumatoid arthritis. , 2005, The Journal of rheumatology. Supplement.

[23]  T. Glant,et al.  Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. , 2004, Methods in molecular medicine.

[24]  T. Kishimoto.  IL-6: from its discovery to clinical applications. , 2010, International immunology.

[25]  Ash A. Alizadeh,et al.  A proteomic approach for the identification of novel lysine methyltransferase substrates , 2011, Epigenetics & Chromatin.

[26]  R. Hay,et al.  Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts , 2007, Proceedings of the National Academy of Sciences.

[27]  Y. Yazici,et al.  Long-term safety of methotrexate in the treatment of rheumatoid arthritis. , 2010, Clinical and experimental rheumatology.

[28]  W. Earnshaw,et al.  Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins , 2009, Current opinion in cell biology.

[29]  T. Dörner,et al.  Current aspects of anti-CD20 therapy in rheumatoid arthritis. , 2010, Current opinion in pharmacology.

[30]  David Bebbington,et al.  VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo , 2004, Nature Medicine.

[31]  M. Loda,et al.  The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. , 2006, Cancer research.

[32]  R. Gay,et al.  DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. , 2009, Arthritis and rheumatism.

[33]  R. Gay,et al.  Epigenetic control in rheumatoid arthritis synovial fibroblasts , 2009, Nature Reviews Rheumatology.

[34]  C. Allis,et al.  Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.

[35]  S. Gay,et al.  The role of resident synovial cells in destructive arthritis. , 2008, Best practice & research. Clinical rheumatology.

[36]  T. Glant,et al.  Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints , 2010, Arthritis research & therapy.

[37]  E. Wagner,et al.  c-Jun Controls Histone Modifications, NF-κB Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene , 2008, Molecular and Cellular Biology.

[38]  G. Haegeman,et al.  Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF‐κB inhibition , 2008, The EMBO journal.

[39]  U. Müller-Ladner,et al.  Side effects and management of side effects of methotrexate in rheumatoid arthritis. , 2010, Clinical and experimental rheumatology.

[40]  T. Glant,et al.  Combined Autoimmune Models of Arthritis Reveal Shared and Independent Qualitative (Binary) and Quantitative Trait Loci 1 , 2003, The Journal of Immunology.

[41]  Marie Nguyen,et al.  A practical approach to RT-qPCR-Publishing data that conform to the MIQE guidelines. , 2010, Methods.

[42]  J. Seyer,et al.  Suppression of murine collagen‐induced arthritis by nasal administration of collagen , 1997, Immunology.

[43]  Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling , 2011, Nature Immunology.

[44]  Andreas Radbruch,et al.  B-cell-directed therapies for autoimmune disease , 2009, Nature Reviews Rheumatology.

[45]  T. Glant,et al.  Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. , 2011, Arthritis and rheumatism.